跳至主要内容
临床试验/CTRI/2019/09/021431
CTRI/2019/09/021431尚未招募不适用

A COMPARATIVE STUDY ON EFFECT OF SHASTRAVARTI ANJANA AND NAYANASUKHAVARTI ANJANA IN THE MANAGEMENT OF ARMA

Dr Sudhakar1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年9月28日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Pictorial presentation

研究概览

简要总结

6       NEED FOR THE STUDY: Arma is the shuklagataroga described in classical texts of Ayurveda by AcharyaSushruta and Vagbhata. Based on site of manifestation, clinical presentation and surgical method of management Arma can be compared with pterygium which is  common disorder of ocular surface. The epidemiological studies have shown that the prevalence rates of Pterygium range between 0.3% and 37.46% globally.Pterygium prevalence in rural central India is about 13%, among the adult Indian aged above 30 years.Older age, male gender, lower educational level and more time spent outdoors with vigorous were associated factors.

Pterygium is a fibro vascular degeneration of conjunctiva, commonly encroaching on to the cornea. It is usually triangular or wing shaped. It not only affects beautiful outlook of the patient, but also leads refractive astigmatism and is a potentially blinding disease in the advanced stage due to invasion of the visual axis, which can have significant impact on vision.

Basically treatment of pterygium in modern medicine is surgical excision, 90% pterygium surgeries are successful, and complications though rare are more serious. Even though surgical treatments are available, the hardship caused due to the surgery and the cost associated with it is high and recurrence rate is 30-50%. Considering these lacunas in modern science has stressed upon the need for the study for effective measure which can cure the condition and prevent recurrence and hence the present study has been taken up.

HYPOTHESIS:

NULL HYPOTHESIS-

H0: Shastravartianjan has no effect in arma management.

ALTERNATE HYPOTHESIS-

*H1: There will be significant effect of shastravartianjana in the management of arma.

*H2: There will be significant effect of Nayanasukhavartianjana in the management of arma.             *H3: Both Shastravartianjan and Nayansukhavartianjana have significant effect in the management of arma.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Clinical features as per classics
  • Pterygium which limited to limbus.

排除标准

  • Those who suffering from conjunctival Xerosis,Vit-A deficiency and Xeropthalamia.
  • Acute Infections of eye.
  • Pseudopterygium
  • Those contraindicated for Anjana therapy.
  • Subject suffering from any chronic Debilitating disorders.

结局指标

主要结局

Pictorial presentation

时间窗: 2 months

次要结局

  • Visual acuity(2 months)

研究者

发起方
Dr Sudhakar
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验